Related Experiment Videos
Endothelial dysfunction in chronic heart failure. Experimental and clinical studies
1Medizinische Klinik III, University of Freiburg, Fed. Rep. of Germany.
Arzneimittel-Forschung
|March 1, 1994
Summary
Endothelial dysfunction, marked by reduced nitric oxide release, contributes to vasoconstriction in chronic heart failure (CHF). Impaired endothelium-dependent dilation in peripheral vessels is evident in CHF patients compared to healthy individuals.
Area of Science:
- Cardiovascular Physiology
- Endothelial Function
- Nitric Oxide Biology
Background:
- The endothelium regulates vascular tone via nitric oxide (NO) release.
- Endothelial dysfunction may cause vasoconstriction in chronic heart failure (CHF).
Purpose of the Study:
- To investigate in vivo endothelial function in patients with chronic heart failure.
- To assess the role of nitric oxide synthesis and release in CHF-related vascular changes.
Main Methods:
- Administered acetylcholine to stimulate endothelium-derived nitric oxide (EDNO) release.
- Used N-mono-methyl-L-arginine (L-NMMA) to inhibit nitric oxide synthesis.
- Measured forearm blood flow responses to vasodilators and vasoconstrictors.
Main Results:
- Blood flow response to acetylcholine was blunted in CHF patients.
- L-NMMA caused a more pronounced decrease in blood flow in CHF patients.
- Endothelium-independent vasodilation to nitroglycerin was preserved, but flow-dependent dilation was impaired in CHF.
Conclusions:
- Impaired endothelium-dependent vasodilation is present in the peripheral resistance vessels of CHF patients.
- Reduced nitric oxide release contributes to endothelial dysfunction in chronic heart failure.
- Endothelial dysfunction plays a role in the reduced vasodilator capacity observed in CHF, potentially impacting exercise tolerance.